Contact
Please use this form to send email to PR contact of this press release:
Menlo Therapeutics Announces Results from Phase 2 Trial of Serlopitant in Patients with Chronic Pruritus of Unknown Origin
TO:
Please use this form to send email to PR contact of this press release:
Menlo Therapeutics Announces Results from Phase 2 Trial of Serlopitant in Patients with Chronic Pruritus of Unknown Origin
TO: